Skip to main content

Tasigna 200mg capsules (Nilotinib)| Apple Pharmaceuticals

Tasigna 200mg capsules (Nilotinib)

Apple Pharmaceuticals


description

Tasigna is cancer drugs, the main ingredient which is used as lapatinib, which prohibits growth of the tumor cells. Nilotinib Tasigna 200mg capsules is sold under the brand name Tasigna< which is a targeted cancer medication Tasigna tablet belongs to the class of kinase inhibitors. The medicine Tasigna in children younger than Tasigna 200mg  1 year has no safety and efficacy not been established The drug Tasigna is a prescription drugs, which is used under the knowledge of medical oncologist.

DOSAGE

The usual dose of Tasigna 200mg capsules Tablet should be given as twice daily at 12 hours time intervals Tasigna must be administer on an empty stomach Taking of food should not be at least 1 hour after the dose is taken or 2 hours before the dose is taken Who are unable to taken the Tasigna capsules, the patients can be dispersed the tablet in one teaspoon of applesauce. This tablet should be administer immediately within 15 minutes Tasigna should be combination with hematopoietic Tasigna 200mg  growth factors such as erythropoietin or G-CSF Also concomitant use with hydroxyurea or anagrelide

Dosage in adult patients with Philadelphia positive CML-CP:

The regular dose of the Tasigna 200mg capsules tablet in this condition given is 300mg should be given orally as twice daily.

With resistant or intolerant Philadelphia positive CML-CP and CML-AP:

The normal dose is 400mg should be administered as orally twice in a day.

In pediatrics:

The normal dose 230mg/m2 should be administer orally twice daily The maximum dose of Tablet Tasigna 200mg.

PHARMACOKINETICS

Absorption: 
The Tasigna 200mg  has bioavailability about 50% The time of peak plasma concentration is occurred within 3 hours after administration. 
Distribution: 
The Tasigna has serum protein binding is approximately 98% The Nilotinib blood to serum ratio is 0.68 
Metabolism: 
Tasigna 200mg capsules is metabolized via CYP3A4 mediated oxidation. The prime flowing component in the blood stream is Nilotinib. 
Elimination: 
The half life period of Tasigna Tablet is approximately 17 hours. The mean apparent clearance value is 29L/hr. 
Effect of food: 
The effect of drug is increased to 82% when the dose was given 30 minutes after a high fat meal when compared to fasted patient.

MECHANISM OF ACTION

CML: chronic myelogenous leukemia is caused by BCR-ABL oncogene.Tasigna (nilotinib) is a kinase inhibitor, which prohibits BCR-ABL kinase activity. Binding of Tasigna to the ATP-binding site Tasigna 200mg  of BCR-ABL protein. The drug Tasigna prevents the proliferation of murine leukemic cell lines and human cell lines derived from patients with Philadelphia positive CML

PRECAUTION

Tasigna may cause thrombocytopenia, neutropenia and anemia, so check blood counts periodically to reduce these complications

Embryo fetal damage

While using this in pregnancy then the drug Tasigna 200mg capsules causes fetal damage Examine the patients properly who are stop the Tasigna therapy, the range of Bcr-Abl transcripts level. Use the drug with caution while using Tasigna 200mg  in patient who are suffered with Hypokalemia Hypomagnesemia Hepatotoxicity Electrolyte abnormalities

Long QT syndrome

Monitor ECG frequently Avoid concomitant use of Tasigna 200mg  with anti-arrhythmia agents Provide supportive measures

Pancreatitis and elevated lipase

Patient suffering with pancreatitis may have serum lipase levels increase, this may results in abdominal symptoms and to decrease Tasigna 200mg capsules the problems, treatment should be postponed & undergone with appropriate diagnostics. Test serum lipase value periodically.

Tumor lysis syndrome

Maintain with sufficient hydration Balance the level of uric acid before starting the treatment.

DRUG INTERACTION

While interaction of strong CYP3A inhibitors with Tasigna drug interactions leads to increase nilotinib concentrations compared to while using Tasigna 200mg  alone Concomitant use with strong CYP3A inducer leads to reduce nilotinib concentration Tasigna interaction With proton pump inhibitors: decrease the Tasigna efficacy Avoid combination of Tasigna with drugs that may prolong the QT interval like anti-arrhythmic drugs.

CONTRAINDICATION

Tasigna tablet is contraindicated in the patients who are having; Hypokalemia Hypomagnesemia Long QT syndrome

MISSED DOSE

If patients missed to have the dose , then administer the dose of Tasigna 200mg capsules should be take within the time, or the missed dose should be swapped and continue the next dosing schedule. Consult with your doctor for more clarification

STORAGE

Stored at between Tasigna 200mg  68℉ to 77℉ (20℃ to 25℃) room temperature keep away from heat, moisture and light.

SIDE EFFECTS

Tasigna side effects, General: Fatigue, pyrexia, asthenia, peripheral edema, face edema
Pulmonary: Dyspnae , Cough, oropharyngeal pain, 
Skin: Rash, Pruritus, alopecia, dry skin
GIT: Nausea, constipation, diarrhea, vomiting, upper abdominal pain, dyspepsia
Nerve system: Dizziness , Headache,
Vascular: Hypertension
Muscle: Myalgia, arthralgia, muscle spasm, pain in extremity, back pain
Infections & infestations: Nasopharyngitis, upper respiratory tract infection, influenza, gastroenteritis
Eye: Eyelid edema, periorbital edema
Psychiatric: Insomnia, this are the tasigna side effects.

Contact Us


phone No      :9987711567

Email             :info@myapplepharma.com


website

Comments

Popular posts from this blog

Afatinib 20mg | Afatinib 20mg tablet | Xovoltib | Apple pharmaceuticals

Afatinib 20mg | Afatinib 20mg tablet   Apple pharmaceuticals Afatinib 20mg | Afatinib 20mg tablet |  Xovoltib 20mg | Xovoltib 20mg tablet Afatinib 20mg tablet Xovoltib 20mg  belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 20mg  is a prescription drugs which is used under the guidance of medical practioners. INDICATION Xovoltib 20mg  is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE Xovoltib the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of a...

Afatinib 20mg | Afatinib 20mg tablet | Xovoltib | Apple pharmaceuticals

Afatinib 20mg |  Afatinib 20 mg comprimat   Produse farmaceutice Apple Afatinib 20mg  |  Afatinib 20 mg comprimat  |  Xovoltib 20mg  |  Tableta Xovoltib 20mg Afatinib 20 mg comprimat Xovoltib 20mg   aparține derivatului de chinazolină și butanamidă, care acționează ca un inhibitor al tirozin kinazei a receptorilor factorilor de creștere a epidermiei (RECEPTORI ERBB) și este utilizat în tratamentul CANCERULUI  LUNGULUI CU CELULE MICIUNE MICASTIC  . Xovoltib 20mg   este un medicament care se eliberează pe bază de rețetă, care este utilizat sub îndrumarea practicienilor medicali. INDICAŢIE Xovoltib 20mg   este indicat pentru tratamentul unui anumit tip de cancer pulmonar (cancer pulmonar cu celule mici) care s-a răspândit în alte părți ale corpului. DOZARE Xovoltib doza prescrisă pentru tratamentul cancerului pulmonar cu celule mici, după cum urmează: Pentru adult: ...

Tasigna 150mg (Nilotinib) capsules | Apple pharmaceuticals

Tasigna 150mg (Nilotinib) capsules Apple pharmaceuticals  Tasigna 150mg | Tasigna 150mg  capsules | Nilotinib 150mg | Nilotinib150mg capsules description Tasigna 150mg  is cancer drugs, the main ingredient which is used as  lapatinib , which prohibits growth of the tumor cells. Nilotinib is sold under the brand name  Tasigna  which is a targeted cancer medication Tasigna tablet belongs to the class of kinase inhibitors. The medicine Tasigna in children younger than 1 year has  Tasigna 150mg  capsules  no safety and efficacy not been established The drug Tasigna is a prescription drugs, which is used under the knowledge of medical oncologist. DOSAGE The usual dose of  Tasigna  Tablet should be given as twice daily at 12 hours time intervals Tasigna must be administer on an empty stomach Taking of food should not be at least 1 hour after the dose is taken or 2 hours before the dose is taken Who are unable to ta...